A UK SME has patented and launched an innovative kit that greatly simplifies direct antibody labelling (conjugation). It allows an end user with no prior knowledge to carry out the procedure with 30 seconds hands-on time. There is no loss of antibody, and the method is fully scalable from 10ug up to 10mg for benefit of manufacturers. Researchers using immunoassays are sought for commercial agreements with technical assistance, and commercial developers of diagnostic kits for licensing.
For further information, please contact:
María Fernández firstname.lastname@example.org